28,102 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by APG Asset Management N.V.

APG Asset Management N.V. bought a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 28,102 shares of the medical technology company’s stock, valued at approximately $4,830,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Teleflex during the 4th quarter valued at $100,328,000. Invesco Ltd. grew its holdings in Teleflex by 48.1% during the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock valued at $190,188,000 after purchasing an additional 347,003 shares during the period. Diamond Hill Capital Management Inc. purchased a new stake in Teleflex in the fourth quarter worth about $46,696,000. Magnetar Financial LLC raised its stake in shares of Teleflex by 105.2% in the fourth quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company’s stock worth $74,990,000 after buying an additional 215,961 shares during the period. Finally, Cooke & Bieler LP lifted its position in shares of Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after buying an additional 195,150 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Up 0.6 %

TFX opened at $129.81 on Friday. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a 50-day simple moving average of $148.00 and a two-hundred day simple moving average of $181.53. The company has a market capitalization of $6.02 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.05%. Teleflex’s dividend payout ratio (DPR) is currently 95.77%.

Analyst Ratings Changes

TFX has been the subject of several analyst reports. Wells Fargo & Company reduced their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Piper Sandler restated a “neutral” rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Finally, Raymond James downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Teleflex presently has a consensus rating of “Hold” and a consensus price target of $181.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.